This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Female genital organ, unspecified
CD2_BENIGN_FEMALE_GEN_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D28
- Name in latin
- Neoplasma benignum organi genitalis feminini non specificati
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Female genital organ, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Female genital organ, unspecified
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasm of other and unspecified female genital organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 108 | 108 | - |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | - |
| Median age at first event (years) | 39.04 | 39.04 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 95
- Matched controls
- 950
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D28.9
ICD-10 Finland
Benign neoplasm: Female genital organ, unspecified
+∞
65.3
55
*
22199
ICD-8 Finland
Benign neoplasm of other female genital organs, Unspecified site
+∞
30.9
28
*
2218X
ICD-9 Finland
Benign neoplasm of other female genital organs, Other specified sites of female genital organs
+∞
9.5
9
*
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
30.7
8.7
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
17
72
2.62
2.90
3.2
2.8
—
—
—
0
0
11
39
3.03
2.56
1.2
1.4
—
—
—
0
0
29
172
1.94
2.23
2.1
1.7
440.5
466.0
pmol/l
0.22
22
141
8
24
3.51
2.23
2.1
1.5
—
—
—
0
0
7
21
3.49
2.00
1.9
1.5
—
—
—
0
0
35
232
1.75
1.87
4.3
3.9
0.0
0.0
estimate
0.00
15
79
5
12
4.31
1.84
1.0
1.2
—
—
—
0
0
7
23
3.18
1.83
1.6
1.5
—
—
—
0
0
81
678
1.78
1.80
7.1
5.0
73.1
75.6
u/l
0.38
73
611
12
56
2.29
1.68
2.7
2.7
1.2
1.2
mmol/l
0.55
12
48
41
306
1.55
1.33
3.0
1.9
2.4
2.4
mmol/l
0.06
34
258
47
368
1.49
1.20
4.7
3.6
—
—
—
0
0
37
279
1.50
1.12
2.1
2.4
30.8
27.3
u/l
0.35
32
270
30
217
1.53
1.10
1.6
1.5
27.2
23.1
nmol/l
0.52
24
189
37
284
1.46
1.02
2.2
2.0
55.4
55.4
u/l
0.00
32
257
51
416
1.43
1.02
3.2
3.6
—
—
—
0
0
57
477
1.41
0.97
4.5
3.7
0.0
0.0
estimate
0.00
15
77
50
409
1.41
0.97
2.6
2.3
76.9
79.2
nmol/l
0.23
44
363
13
195
0.62
0.82
1.5
1.7
—
—
—
0
0
55
469
1.35
0.79
3.9
3.6
0.0
0.0
estimate
0.00
15
81
55
471
1.34
0.76
6.0
5.1
0.0
0.0
estimate
0.00
15
77
66
581
1.35
0.76
3.0
2.9
43.6
39.7
u/l
0.22
59
541
17
119
1.51
0.72
4.6
4.4
34.8
33.3
%
—
10
77
56
487
1.31
0.67
7.9
6.3
3.7
4.1
e9/l
1.00
47
422
5
28
1.82
0.67
1.4
1.3
65.2
57.7
pmol/l
—
5
28
0
21
0.00
0.60
0.0
1.7
—
—
—
0
0
17
124
1.44
0.60
2.0
1.6
—
—
—
0
0
14
100
1.46
0.55
5.4
5.8
—
—
—
0
0
92
871
1.38
0.51
11.3
10.0
80.8
80.3
ml/min/173m2
0.08
79
685
48
421
1.25
0.50
3.2
2.7
88.0
75.4
ug/l
0.19
41
392
45
392
1.25
0.50
6.7
4.0
1.2
1.2
mmol/l
0.02
40
352
21
165
1.34
0.50
2.6
1.6
1191.0
1152.5
nmol/l
0.06
13
131
7
46
1.56
0.49
1.4
3.0
24.5
25.8
mmol/l
—
7
46
76
705
1.26
0.47
4.1
4.4
11.1
12.2
mm/h
0.49
68
640
64
583
1.24
0.47
2.7
3.2
—
—
—
0
0
28
232
1.28
0.46
3.1
2.9
0.6
0.6
e6/l
0.02
23
161
29
244
1.26
0.42
2.1
2.4
1052.5
989.3
ng/l
0.04
22
209
5
33
1.54
0.42
2.4
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
8
60
1.36
0.41
1.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.0
—
3.8
—
0
6
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.49
0.41
2.2
1.6
—
—
—
0
0
25
208
1.26
0.40
2.7
2.2
328.1
7760.7
umol/l
1.34
16
183
89
926
0.78
0.37
5.1
4.6
5.9
5.9
mmol/l
0.03
82
855
6
43
1.42
0.35
1.5
1.3
—
—
—
0
0
6
43
1.42
0.35
1.2
1.6
—
—
—
0
0
6
44
1.38
0.35
1.8
1.5
—
—
—
0
0
23
195
1.23
0.31
1.4
1.8
—
—
—
0
0
25
216
1.20
0.29
1.8
2.0
3.0
3.1
mg/l
0.05
18
183
23
200
1.19
0.25
1.4
1.3
37.5
44.4
iu/ml
—
6
70
7
91
0.75
0.23
10.9
4.4
4.8
2.2
mmol/l
—
7
75
5
40
1.26
0.23
1.6
1.3
—
—
—
0
0
23
202
1.18
0.22
1.6
1.7
0.8
1.0
mg/l
0.60
17
159
11
134
0.80
0.22
2.2
2.7
7.4
4.6
e6/l
—
6
62
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
19
217
0.85
0.21
1.6
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
85.4
—
0
5
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
1.3
—
0
6
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
117.9
—
0
14
92
943
0.84
0.20
5.0
5.1
2.7
2.8
mmol/l
0.27
84
872
80
771
1.15
0.20
4.7
4.3
14.7
14.6
pmol/l
0.20
74
715
7
57
1.24
0.19
1.3
1.7
—
—
—
0
0
7
57
1.24
0.19
1.1
1.2
—
—
—
0
0
8
67
1.21
0.17
2.1
1.5
—
—
—
0
0
22
200
1.13
0.13
1.2
1.3
1.3
18.2
u/ml
—
5
72
50
522
0.92
0.12
4.7
3.6
6.5
6.5
mmol/l
0.01
44
475
32
300
1.09
0.12
3.3
2.8
—
—
—
0
0
43
410
1.08
0.11
2.2
1.9
99.8
100.2
pmol/l
0.02
21
188
5
43
1.17
0.10
1.8
4.1
1.7
1.5
%
—
5
43
16
146
1.11
0.09
2.0
2.4
1.0
1.4
e6/l
0.32
11
74
7
82
0.84
0.07
2.3
1.6
—
—
—
0
0
9
84
1.08
0.07
1.4
1.6
—
—
—
0
0
9
85
1.06
0.07
1.4
1.6
—
—
—
0
0
93
918
1.09
0.06
12.2
11.3
22.1
19.1
mg/l
0.28
75
696
12
110
1.10
0.05
1.8
2.3
—
—
—
0
0
87
860
1.06
0.04
5.8
5.7
38.5
39.3
mmol/mol
0.49
79
807
32
328
0.97
0.02
5.1
3.4
15.2
134.9
ng/l
0.54
17
213
24
233
1.04
0.01
1.1
1.3
0.4
1.8
u/ml
—
5
55
27
277
0.97
0.01
1.6
1.6
1.5
1.3
mmol/l
0.39
19
236
87
873
0.98
0.00
4.0
4.1
1.2
1.2
mmol/l
0.14
77
797
91
915
0.97
0.00
4.6
4.4
1.6
1.6
mmol/l
0.11
83
848
90
895
1.03
0.00
5.8
5.2
1.7
1.9
mu/l
1.01
85
835
92
924
0.97
0.00
4.5
4.5
4.7
4.8
mmol/l
0.25
84
859
10
95
1.06
0.00
1.8
2.1
—
—
—
0
0
44
436
1.02
0.00
7.1
4.5
1.2
1.2
mmol/l
0.12
35
379
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
5
58
0.86
0.00
2.4
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_FEMALE_GEN_NOS_EXALLC – Benign neoplasm: Female genital organ, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).